Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis

IM Zacharioudakis, FN Zervou, EE Pliakos… - Official journal of the …, 2015 - journals.lww.com
Objectives: It has been suggested that colonization withC. difficileprotects from infection.
Nevertheless, the association between carriage of toxinogenic strains and ensuingC …

Clostridioides difficile infection in children: Recent updates on epidemiology, diagnosis, therapy

DA Shirley, W Tornel, CA Warren, S Moonah - Pediatrics, 2023 - publications.aap.org
Clostridioides (formerly Clostridium) difficile is the most important infectious cause of
antibiotic-associated diarrhea worldwide and a leading cause of healthcare-associated …

Fecal microbiota transplantation for recurrent Clostridium difficile infection and other conditions in children: a joint position paper from the North American Society for …

ZH Davidovics, S Michail, MR Nicholson… - Journal of pediatric …, 2019 - journals.lww.com
Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against
recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology …

Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options

S Di Bella, G Sanson, J Monticelli… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections.
This bacterium is constantly evolving and poses complex challenges for clinicians, often …

Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter …

J Wolf, K Kalocsai, C Fortuny, S Lazar… - Clinical Infectious …, 2020 - academic.oup.com
Background Fidaxomicin, a narrow-spectrum antibiotic approved for Clostridioides
(Clostridium) difficile infection (CDI) in adults, is associated with lower rates of recurrence …

Bacteriotherapy for clostridium difficile colitis

EJ Hlavka - US Patent 9,629,881, 2017 - Google Patents
This document discusses, among other things, receiving a plurality of donor fecal samples
from a plurality of donors and storing and indexing each respective donor fecal samples …

Detection of 23 gastrointestinal pathogens among children who present with diarrhea

C Stockmann, AT Pavia, B Graham… - Journal of the …, 2017 - academic.oup.com
Background Diarrheal diseases are a major cause of ambulatory care visits and
hospitalizations among children. Because of overlapping signs and symptoms and …

[HTML][HTML] How to: Clostridioides difficile infection in children

M Krutova, TGJ de Meij, F Fitzpatrick, RJ Drew… - Clinical Microbiology …, 2022 - Elsevier
Background Clostridioides difficile infections (CDI) are traditionally attributed to an older
adult patient group but children can also be affected. Although the causative pathogen is the …

Microbiota restoration therapy (MRT), compositions and methods of manufacture

LA Jones, CR Jones, EJ Hlavka, RD Gordon - US Patent 9,511,100, 2016 - Google Patents
Microbiota restoration therapy compositions and methods for manufacturing, processing,
and/or delivering microbiota restoration therapy compositions are disclosed. An example …

Prevalence of detection of Clostridioides difficile among asymptomatic children: a systematic review and meta-analysis

SR Tougas, N Lodha, B Vandermeer… - JAMA …, 2021 - jamanetwork.com
Importance Detection ofClostridioides difficilehas frequently been described in
asymptomatic infants and children, but accurate estimates across the age spectrum are …